Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice

Journal of Biosciences

Volumn 40, Issue 2, 2015, Pages 269-279

  Hu, Jingtao ^a,b   Wang, Chunfeng ^b   Ye, Liping ^b   Yang, Wentao ^b   Huang, Haibin ^b   Meng, Fei ^b,c   Shi, Shaohua ^b   Ding, Zhuang ^a  

^a JILIN UNIVERSITY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c GUANGXI VETERINARY RESEARCH INSTITUTE   (China)

Author keywords

Colon cancer; CT26 cells; immunity; Lactobacillus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; PROBIOTIC AGENT; ANTINEOPLASTIC AGENT;

CANCER; DISEASE TREATMENT; IMMUNITY; LABORATORY METHOD; MICROBIAL ACTIVITY; PROBIOTICS; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLON ADENOCARCINOMA; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MITOSIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN POLYMORPHISM; SURVIVAL TIME; TH1 CELL; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; COLORECTAL NEOPLASMS; IMMUNOLOGY; ORAL DRUG ADMINISTRATION; TUMOR CELL LINE;

LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MURINAE; MUS;

ADENOCARCINOMA; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; KILLER CELLS, NATURAL; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MICE; MICE, INBRED BALB C; PROBIOTICS;

EID: 84930374913     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-015-9518-4     Document Type: Article

References (49)

1. Abou-Elkacem L, Arns S, Brix G, Gremse F, Zopf D, Kiessling F and Lederle W 2013 Regorafenib inhibits growth, angiogenesis, metastasis in a highly aggressive, orhotopic colon cancer model. Mol. Cancer Ther.12 1322–1331
2. Al-Hassi HO, Mann ER, Sanchez B, English NR, Peake ST, Landy J, Man R, Urdaci M, et al. 2014 Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp. Mol. Nutr. Food Res.58 1132–1143
3. Arthur JC, Gharaibeh RZ, Uronis JM, Perez-Chanona E, Sha W, Tomkovich S, Mühlbauer M, Fodor AA, et al. 2013 VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci. Rep.3 1–9
4. Azcárate-Peril MA, Sikes M and Bruno-Bárcena JM 2011 The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am. J. Physiol. Gastrointest. Liver. Physiol.301 G401–G424
5. Bäuerl C, Llopis M, Antolín M, Monedero V, Mata M, Zúñiga M, Guarner F and Martínez GP 2013 Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa. Genes Nutr.8 165–180
6. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C and Sartor RB 2005 VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol.100 1539–1546
7. Chen L, He Z, Qin L, Li Q, Shi X, Zhao S, Chen L, Zhong N, et al. 2011 Antitumor effect of Malaria Parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity. PLoS One6 1–10
8. Chien CC, Lin WC, Kong MS, Shi HN, Allan Walker W, Lin CY, Huang CT, Lin YC, et al. 2012 Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue. Br. J. Nutr.107 1623–1634
9. Christensen HR, Frøkiær H and Pestka JJ 2002 Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol.168 171–178
10. Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y and Roy D 2008 Immunomodulatory effects of probiotics in the intestinal tract. Curr. Issues Mol. Biol.10 37–54
11. Dwivedi A, Nomikou N, Nigam PS and McHale AP 2012 The effects of microencapsulated Lactobacillus casei on tumour cell growth: in vitro and in vivo studies. Int. J. Med. Microbiol.302 293–299
12. Erickson KL and Hubbrad NE 2000 Probiotic immunomodulation in health and disease. J. Nutr.130 403–409
13. Evans C, Dalgleish AG and Kumar D 2006 Review article: immune suppression and colorectal cancer. Aliment. Pharmacol. Ther.24 1163–1177
14. Ewaschuk JB, Walker JW, Diaz H and Madsen KL 2006 Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J. Nutr.136 1483–1487
15. Francois P, Douillard AR, Kant R, Taija E, Pietilä HM, Järvinen MM, Cinzia L, Randazzo LP, et al. 2013 Comparative genomic and functional analysis of 100 Lactobacillus rhamnosus strains and their comparison with strain GG. PLoS Genet.9 1–15
16. Gao X and Xiong S 2011 Medical immunology 2nd ed., Vol. 80 (Beijing: Higher Education Press) p 144
17. Geier MS, Butler RN and Howarth GS 2006 Probiotics, Prebiotics and Synbiotics: A Role in Chemoprevention for Colorectal Cancer? Cancer Biol. Therapy5 1265–1269
18. Ghoneum M and Gollapudi S 2004 Induction of apotosis in breast cancer cells by Saccharomyces Cerevisiae, the baker’s yeast, in vitro. Anticancer Res.24 1455–1464
19. Hirayama K and Rafter J 2000 The role of probiotic bacteria in cancer prevention. Microbes Infect.2 681–686
20. Horinaka M, Yoshida T, Kishi A, Akatani K, Yasuda T, Kouhara J, Wakada M and Sakai T 2010 Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells. FEBS Lett.584 577–582
21. +T cell accumulation in tumors. Mol. Cancer13 34
22. Jemal A, Siegel R, Xu J and Ward E 2010 Cancer statistics. CA Cancer J. Clin.60 277–300
23. Kalliomäki M and Isolauri E 2003 Role of intestinal flora in the development of allergy. Curr. Opin. Allergy Clin. Immunol.3 15
24. Kandasamy M, Bay B-H, Lee Y-K and Mahendran R 2011 Lactobacilli secreting a tumor antigen and IL-15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells. Cell. Immunol.271 89–96
25. Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, Kim JY, Joo HG and Woo HJ 2004 Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacrerium longum. J. Vet. Sci.5 41–48
26. Li S, Zhao Y, Zhang L, Zhang X, Huang L, Li D, Niu C, Yang Z, et al. 2012 Antioxidant activity of Lactobacillus plantarum strains isolated from traditional Chinese fermented foods. Food Chem.135 1914–1919
27. Linsalata M and Russo F 2008 Nutritional factors and polyamine metabolism in colorectal cancer. Nutrition24 382–389
28. Liong MT 2008 Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in vivo evidence. Int. J. Mol. Sci.9 854–863
29. Maassen CB, van Holten-Neelen C, Balk F, den Bak-Glashouwer MJ, Leer RJ, Laman JD, Boersma WJ and Claassen E 2000 Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine18 2613–2623
30. Maroof H, Hassan ZM, Mobarez AM and Mohamadabadi MA 2012 Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J. Clin. Immunol.32 1353–1359
31. Marshall JR 2008 Prevention of colorectal cancer: diet, chemoprevention, and lifestyle. Gastroenterol. Clin. N. Am.37 73–82
32. Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S and Klaenhammer TR 2005 Lactobacilli activate human dendritic cells that skew T cells toward T-helper 1 polarization. Proc. Natl. Acad. Sci. USA7 1155–1164
33. Mohamadzadeh M, Duong T, Hoover T and Klaenhammer TR 2008 Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev. Vaccines7 163–174
34. 2mice. Exp. Anim.59 487–494
35. Ni J, Galani IE, Cerwenka A, Schirrmacher V and Fournier P 2011 Antitumor vaccination by Newcastle Disease Virus Hemagglutinin–Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity. Vaccine29 1185–1193
36. Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, et al. 2007 Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomized study. Br. J. Cancer97 1028–1034
37. Qiao J, Kottke T, Willmon C, Galivo F, Wongthida P, Diaz RM, Thompson J, Ryno P, et al. 2008 Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy. Oncolytic Virotherapy Immunother.14 37–44
38. Qureshi A, Itankar Y, Ojha R, Mandal M, Khardenavis A and Kapley A 2014 Genome sequence of Lactobacillus plantarum EGD-AQ4, isolated from fermented product of Northeast India. Genome Announcements2 1–2
39. Rafer J 2003 Probiotics and colon cancer. Best Pract. Res. Clin. Gastroenterol.17 849–859
40. Schiavi E, Barletta B, Barone A, Butteroni C, Corinti S and DiFelice G 2011 Probiotic treatment induces intestinal regulatory dendritic and T cells, and counter-regulates Th2 responses and anaphylaxis in a mouse model of food allergy. Clin. Transl. Allergy1 1
41. Seow SW, Cai S, Rahmat JN, Bay BH, Lee YK, Chan YH and Mahendran R 2010 Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors. Cancer Sci.101 751–758
42. Shen H, Tang G, Zeng G, Yang Y, Cai X, Li D, Liu H and Zhou N 2013 Purification and characterization of an anti-tumor polysaccharide from Portulaca oleracea L. Carbohydr. Polym.93 395–400
43. Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, Yagita H and Okumura K 2001 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon c-dependent natural killer cell protection from tumor metastasis. J. Exp. Med.3 661–670
44. Sun J, Shi YH, Le GW and Ma XY 2005 Distinct immune response induced by peptidoglycan derived from Lactobacillus sp. World J. Gastroenterol.11 6330–6337
45. Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M and Yokokura T 2001 Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis22 599–605
46. Wang SM, Zhang LW, Fan RB, Han X, Yi HX, Zhang LL, Xue CH, Li HB, et al. 2014 Induction of HT-29 cells apoptosis by lactobacilli isolated form fermented products. Institut Pasteur.165 202–214
47. Wykes MN, Liu XQ, Jiang S, Hirunpetcharat C and Good MF 2007 Systemic tumor necrosis factor generated during lethal Plasmodium infections impairs dendritic cell function. J. Immunol.179 3982–3987
48. Yazdi MH, Mahdavi M, Setayesh N, Esfandyar M and Shahverdi AR 2013 Selenium nanoparticle-enriched Lactobacillus brevis causes more efficient immune responses in vivo and reduces the liver metastasis in metastatic from of mouse breast cancer. DARU J. Pharm. Sci.21 33–41
49. Yu J, Wang WH, Menghe BLG, Jiri MT, Wang HM, Liu WJ, Bao QH, Lu Q, et al. 2011 Diversity of lactic acid bacteria associated with traditional fermented dairy products in Mongolia. J. Dairy Sci.94 3229–3241